NCT00096798View on ClinicalTrials.gov

Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Depressive DisorderDepression
Interventions
DRUG

Ethyl-eicosapentanoic acid (ethyl-EPA)

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00096798 - Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression | Biotech Hunter | Biotech Hunter